(ONC) BeiGene - Performance 63.3% in 12m
Compare ONC with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
23.54%
#23 in Group
Rel. Strength
92.30%
#615 in Universe
Total Return 12m
63.32%
#24 in Group
Total Return 5y
85.92%
#24 in Group
P/E -
(?) Percentile in Group
P/E Forward 370
92th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -2.65%
68th Percentile in Group
12m Total Return: ONC (63.3%) vs XBI (-5.4%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: ONC vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ONC
Total Return (including Dividends) | ONC | XBI | S&P 500 |
---|---|---|---|
1 Month | -5.68% | 5.55% | -0.45% |
3 Months | 14.45% | -9.75% | -6.29% |
12 Months | 63.32% | -5.39% | 13.04% |
5 Years | 85.92% | -13.20% | 111.82% |
Trend Score (consistency of price movement) | ONC | XBI | S&P 500 |
1 Month | 34.7% | 70% | 47.5% |
3 Months | 19.6% | -88.1% | -87.3% |
12 Months | 82.2% | -44.4% | 54.3% |
5 Years | -42.8% | -53.6% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #147 | -10.6% | -5.26% |
3 Month | #28 | 26.8% | 22.1% |
12 Month | #24 | 72.6% | 44.5% |
5 Years | #24 | 114% | -12.2% |
FAQs
Does ONC BeiGene outperforms the market?
Yes,
over the last 12 months ONC made 63.32%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months ONC made 14.45%, while XBI made -9.75%.
Over the last 3 months ONC made 14.45%, while XBI made -9.75%.
Performance Comparison ONC vs Indeces and Sectors
ONC vs. Indices ONC is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -2.35% | -5.23% | 26.8% | 50.3% |
US NASDAQ 100 | QQQ | -3.27% | -7.58% | 26.1% | 48.4% |
US Dow Jones Industrial 30 | DIA | -1.81% | -2.83% | 27.5% | 54.1% |
German DAX 40 | DAX | -1.99% | -5.46% | 8.67% | 38.3% |
Shanghai Shenzhen CSI 300 | CSI 300 | 1.30% | -2.47% | 30.5% | 58.4% |
Hongkong Hang Seng | HSI | -1.95% | -4.16% | 26.2% | 50.4% |
India NIFTY 50 | INDA | 0.17% | -10.6% | 26.9% | 60.4% |
Brasil Bovespa | EWZ | -0.72% | -8.51% | 21.1% | 70.1% |
ONC vs. Sectors ONC is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -2.50% | -5.08% | 20.8% | 39.9% |
Consumer Discretionary | XLY | -2.38% | -5.09% | 25.6% | 48.7% |
Consumer Staples | XLP | -0.29% | -4.86% | 22.7% | 52.4% |
Energy | XLE | 1.91% | 8.36% | 31.9% | 72.6% |
Financial | XLF | -1.24% | -3.67% | 19.8% | 40.7% |
Health Care | XLV | 0.35% | -1.01% | 31.9% | 64.6% |
Industrial | XLI | -2.67% | -5.98% | 25.7% | 52.6% |
Materials | XLB | -0.54% | -2.46% | 34.6% | 67.8% |
Real Estate | XLRE | -2.24% | -4.58% | 26.6% | 45.0% |
Technology | XLK | -3.91% | -8.11% | 29.7% | 52.9% |
Utilities | XLU | -1.07% | -5.78% | 22.3% | 42.5% |
Aerospace & Defense | XAR | -3.38% | -12.7% | 12.9% | 35.8% |
Biotech | XBI | -2.19% | -11.2% | 42.1% | 68.7% |
Homebuilder | XHB | -1.08% | -3.60% | 41.7% | 69.5% |
Retail | XRT | -1.11% | -4.52% | 32.7% | 64.8% |